EQR
45
-3
HCA
60
3
STT
60
4
LYB
55
4
EOG
42
3
ED
43
-2
BIIB
37
2
SCHW
45
3
GOOG
59
-4
ADM
36
2
DVN
35
2
EFX
77
2
PAYX
41
2
BXP
49
3
XEL
57
4
LRCX
40
-2
CMA
56
6
PX
58
3
HES
66
5
LH
50
10
EQR
45
-3
HCA
60
3
STT
60
4
LYB
55
4
EOG
42
3
ED
43
-2
BIIB
37
2
SCHW
45
3
GOOG
59
-4
ADM
36
2
DVN
35
2
EFX
77
2
PAYX
41
2
BXP
49
3
XEL
57
4
LRCX
40
-2
CMA
56
6
PX
58
3
HES
66
5
LH
50
10
Financhill
Back

Evofem Biosciences 10K Form

Sell
41

EVFM
Evofem Biosciences

Last Price:
0.0100
Seasonality Move:
-7.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EVFM News And Ratings

See the #1 stock for the next 7 days that we like better than EVFM

EVFM Financial Statistics

Sales & Book Value

Annual Sales: $18.22M
Cash Flow: $109K
Price / Cash Flow: 0
Annual Sales: $-1.45
Price / Book: 0

Profitability

EPS (TTM): -6.04830
Net Income (TTM): $50.52M
Gross Margin: $11.71M
Return on Equity: 0%
Return on Assets: 349.88%

Evofem Biosciences Earnings Forecast

Key Evofem Biosciences Financial Ratios

  • The Gross Profit Margin over the past 5 years for EVFM is 64.26%.
  • The Selling, General & Administrative Expenses for EVFM have been equal to 146.09% of Gross Profit Margin.
  • The Research & Development expenses have been 16.13% of Revenue.
  • The Interest Expense is -7.96% of Operating Income.
  • Per Share Earnings over the last 12 years have been positive in 7 years.

Evofem Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: EVFM
CUSIP: 30048L
Website: evofem.com

Debt

Debt-to-Equity Ratio: -0.6
Current Ratio: 0.09
Quick Ratio: 0.06

Price-to-Earnings

Trailing P/E Ratio: 0.24
Forward P/E Ratio: 0

EVFM Technical Analysis vs Fundamental Analysis

Sell
41
Evofem Biosciences (EVFM) is a Sell

Is Evofem Biosciences a Buy or a Sell?